Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EG.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.1.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GS.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GS.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GS.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GS.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.258.17ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.258.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.258.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
B.1.258.17NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.1.21.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.1.21.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.21.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.21.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.1.37ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.1.37ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.37ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.37NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.39ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.39ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.39ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.39NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EE.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EE.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EE.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EE.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-18639.2US
DV.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DV.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DV.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
ES.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
ES.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
ES.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
ES.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.41ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.41ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.41ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.41NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.19.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.19.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.19.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.19.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.479ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.479ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.479ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.479NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.437ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.437ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.437ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.437NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used